hepatic arterial embolization
Recently Published Documents


TOTAL DOCUMENTS

121
(FIVE YEARS 8)

H-INDEX

27
(FIVE YEARS 1)

2019 ◽  
Vol 42 (8) ◽  
pp. 1135-1141 ◽  
Author(s):  
Brandon J. Newgard ◽  
George I. Getrajdman ◽  
Joseph P. Erinjeri ◽  
Anne M. Covey ◽  
Lynn A. Brody ◽  
...  

2018 ◽  
Vol 31 (05) ◽  
pp. 301-308 ◽  
Author(s):  
Raphael Byrne ◽  
Rodney Pommier

AbstractNeuroendocrine tumors, or carcinoid tumors, of both the midgut and hindgut are quite rare, but their incidence is increasing. Surgery is the treatment of choice in patients who can tolerate an operation and have operable disease. Options for the treatment of metastatic disease include cytoreductive surgery, somatostatin analogues, interferon α, local liver therapies (hepatic arterial embolization, ablation), chemotherapy, Peptide-Receptor Radionucleotide Radiotherapy, angiogenesis inhibitors, and mammalian target of rapamycin inhibitors.


Sign in / Sign up

Export Citation Format

Share Document